A review on newly approved PARP inhibitors: Talazoparib and Olaparib
This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
主要作者: | Karim, Azrin |
---|---|
其他作者: | Islam, Farzana |
格式: | Project report |
语言: | English |
出版: |
Brac University
2024
|
主题: | |
在线阅读: | http://hdl.handle.net/10361/24372 |
相似书籍
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
由: Islam, Saidul
出版: (2022) -
Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
由: Ahmed, Nafisa
出版: (2023) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
由: Meem, Manila
出版: (2023) -
Mutation in DNA polymerase γ: mitochondrial disorders
由: Hossain, Sadman Sanjid
出版: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
由: Jahan, Nusrat
出版: (2024)